Point72 Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73M Buy
+90,000
New +$1.96M ﹤0.01% 2416

Other funds holding TNDM

Point72 Asset Management's TNDM Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Tandem Diabetes Care (TNDM) in Q1 2026: 420,478 shares worth $8.06M. The stake represents 0.01% of the portfolio and ranks #1383 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in TNDM as recently as Q4 2024.

Point72 Asset Management first reported a position in TNDM in Q1 2015 and has held it in 27 quarters since. The position peaked at $66.5M in Q1 2022. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Point72 Asset Management held 420,478 shares of Tandem Diabetes Care worth $8.06M as of Q1 2026.
  • Tandem Diabetes Care was a new Point72 Asset Management position in Q1 2026.
  • Tandem Diabetes Care made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1383 holding.
  • Point72 Asset Management first reported a position in Tandem Diabetes Care in Q1 2015 and has held it in 27 quarters since.
  • Point72 Asset Management's Tandem Diabetes Care position peaked at $66.5M in Q1 2022.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.